Wednesday, November 16, 2022
Print Current Session:
![]() |
|
Wednesday
SESSION 27:
PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: HOW TO SAVE THE “NO OPTION FOR TREATMENT” LIMB OR THE “DESERT FOOT” WITH NO PATENT TARGET ARTERIES
Location: Grand Ballroom East, 3rd Floor
Moderators:Joseph L. Mills, MD / Marco G. Manzi, MD / Hasan H. Dosluoglu, MD |
|
SESSION 27 SCHEDULE | |
1:00 PM - 1:05 PM | No Option CLTI: What Is It: What Are The Actual Options For Treatment |
Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:06 PM - 1:11 PM | Contemporary Survival After Below-Knee Amputation (BKA), Above-Knee Amputation (AKA), Bilateral Amputations For Trauma; For Vascular Disease: It Is Definitely Worthwhile Saving Limbs Especially In Vascular Patients |
Presenter(s):Philip P. Goodney, MD, MS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
VALUE OF PROSTHETIC (PTFE) TIBIAL BYPASSES | |
1:12 PM - 1:17 PM | Value Of Spliced Vein Grafts Versus PTFE Grafts For Bypasses When A Single Autologous Vein Is Inadequate |
Presenter(s):Joseph L. Mills, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:18 PM - 1:23 PM | PTFE Tibial And Peroneal Artery Bypasses Can Save No Option Limbs Which Would Otherwise Require Amputation: They Have Worthwhile Long-Term Patency Rates And Limb Salvage Rates |
Presenter(s):Hasan H. Dosluoglu, MD / Gregg S. Landis, MD / Richard F. Neville, MD / Enrico Ascher, MD / Frank J. Veith, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:24 PM - 1:29 PM | PTFE Tibial And Peroneal Bypasses: Cases With Ultra-Long-Term Patency And Limb Salvage Prove Their Value When There Are No Other Options: Why Do They Work For Some Surgeons But Not Others |
Presenter(s):Gregg S. Landis, MD / Richard F. Neville, MD / Hasan H. Dosluoglu, MD / Frank J. Veith, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:30 PM - 1:35 PM | For Patients Facing Amputation With No Endo Options Or Useable Vein, PTFE Tibial Bypasses Are A Worthwhile Option That Yields Acceptable Mid-Term Patency And Long-Term Limb Salvage Rates |
Presenter(s):R. Clement Darling III, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:36 PM - 1:41 PM | Current Outcomes With PTFE Bypasses To Infrapopliteal (Tibial) Targets: Is There Variability Between Surgeons And Institutions |
Presenter(s):Matthew T. Menard, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
UPDATE ON FOOT VEIN ARTERIALIZATION FOR CLTI | |
1:42 PM - 1:47 PM | Role And Value Of Vein Arterialization: Best Way To Do It And Long-Term Results: From The Pioneer |
Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:48 PM - 1:53 PM | Pathophysiology Of Venous Arterialization And Neo Angiogenesis For No Option CLTI: How To Predict When It Will Work And When It Won’t: What Is The Medial Arterial Calcification (MAC) Score And Its Significance |
Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:54 PM - 1:59 PM | Pivotal US Trial (PROMISE II), US Feasibility Study (PROMISE I) And European 2-Year Registry Results With Deep Vein Arterialization With The LimFlow Device For CLTI With Gangrene Shows Reasonable Limb Salvage And Wound Healing |
Presenter(s):Daniel G. Clair, MD / Andrej Schmidt, MD / Daniela Branzan, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:00 PM - 2:05 PM | How To Perform The LimFlow Procedure: Equipment Required And Technical Tips |
Presenter(s):Miguel F. Montero, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:06 PM - 2:11 PM | Deep Vein Arterialization And Valve Lysis By Surgical Means For No Option Desert Feet With Gangrene: How To Do It And Results |
Presenter(s):Richard F. Neville, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:12 PM - 2:18 PM | Panel Discussion |
END OF SESSION 27 | |
previous | next |